Systematic Analysis of Gene Expression in Lung Adenocarcinoma and Squamous Cell Carcinoma with a Case Study of FAM83A and FAM83B

被引:14
|
作者
Cai, Ling [1 ,2 ,3 ]
Luo, Danni [1 ]
Yao, Bo [1 ]
Yang, Donghan M. [1 ]
Lin, Shin Yi [1 ]
Girard, Luc [4 ]
DeBerardinis, Ralph J. [2 ,3 ]
Minna, John D. [4 ]
Xie, Yang [1 ]
Xiao, Guanghua [1 ]
机构
[1] UT Southwestern Med Ctr, Simmons Comprehens Canc Ctr, Dept Populat & Data Sci, Quantitat Biomed Res Ctr, 5323 Harry Hines Blvd, Dallas, TX 75390 USA
[2] UT Southwestern Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA
[3] UT Southwestern Med Ctr, Childrens Med Ctr Res Inst, Dallas, TX 75390 USA
[4] Univ Texas Southwestern Med Ctr Dallas, Simmons Comprehens Canc Ctr, Dept Internal Med, Hamon Ctr Therapeut Oncol Res,Dept Pharmacol, Dallas, TX 75390 USA
来源
CANCERS | 2019年 / 11卷 / 06期
关键词
lung cancer; gene expression difference between tumor and normal; survival association analysis; systematic analysis; meta-analysis; FAM83; CLASS-II EXPRESSION; CANCER; SURVIVAL; EGFR;
D O I
10.3390/cancers11060886
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction: In our previous study, we constructed a Lung Cancer Explorer (LCE) database housing lung cancer-specific expression data and clinical data from over 6700 patients in 56 studies. Methods: Using this dataset of the largest collection of lung cancer gene expression along with our meta-analysis method, we systematically interrogated the association between gene expression and overall survival as well as the expression difference between tumor and normal (adjacent non-malignant tissue) samples in lung adenocarcinoma (ADC) and lung squamous cell carcinoma (SQCC). A case study for FAM83A and FAM83B was performed as a demonstration for hypothesis testing with our database. Results: We showed that the reproducibility of results across studies varied by histological subtype and analysis type. Genes and pathways unique or common to the two histological subtypes were identified and the results were integrated into LCE to facilitate user exploration. In our case study, we verified the findings from a previous study on FAM83A and FAM83B in non-small cell lung cancer. Conclusions: This study used gene expression data from a large cohort of patients to explore the molecular differences between lung ADC and SQCC.
引用
收藏
页数:17
相关论文
共 50 条
  • [41] Massive digital gene expression analysis reveals different predictive profiles for immune checkpoint inhibitor therapy between adenocarcinoma and squamous cell carcinoma of advanced lung cancer
    Kaneda, Toshihiko
    Kurata, Takayasu
    Yoshida, Tomoko
    Kibata, Kayoko
    Yoshioka, Hiroshige
    Yanagimoto, Hiroaki
    Takeda, Kazuhiko
    Yoshida, Takao
    Tsuta, Koji
    BMC CANCER, 2022, 22 (01)
  • [42] Expression of connexin-43 in surgical resections of primary tumor and lymph node metastases of squamous cell carcinoma and adenocarcinoma of the lung: a retrospective study
    Savic, Ivana
    Milovanovic, Petar
    Opric, Svetlana
    Ivanovic, Nebojsa
    Opric, Dejan
    PEERJ, 2022, 10
  • [43] The Comprehensive Characterization of B7-H3 Expression in the Tumor Microenvironment of Lung Squamous Cell Carcinoma: A Retrospective Study
    Asakawa, Ayaka
    Yoshimoto, Ryoto
    Kobayashi, Maki
    Izumi, Nanae
    Maejima, Takanori
    Deguchi, Tsuneo
    Kubota, Kazuishi
    Takahashi, Hisashi
    Yamada, Miyuki
    Ishibashi, Sachiko
    Onishi, Iichiroh
    Kinowaki, Yuko
    Kurata, Morito
    Kobayashi, Masashi
    Ishibashi, Hironori
    Okubo, Kenichi
    Ohashi, Kenichi
    Kitagawa, Masanobu
    Yamamoto, Kouhei
    CANCERS, 2024, 16 (11)
  • [44] Systematic analysis of apoptosis-related genes in the prognosis of lung squamous cell carcinoma: a combined single-cell RNA sequencing study
    Zhu, Peiquan
    Yang, Wenxing
    Wang, Biao
    Zeng, Tao
    Hu, Zhi
    Zhang, Dengguo
    Yang, Ze
    Wang, Kaiqiang
    Pu, Jiangtao
    JOURNAL OF THORACIC DISEASE, 2023, 15 (12) : 6946 - 6966
  • [45] A comprehensive expression analysis of the MIA gene family in malignancies: MIA gene family members are novel, useful markers of esophageal, lung, and cervical squamous cell carcinoma
    Sasahira, Tomonori
    Kirita, Tadaaki
    Nishiguchi, Yukiko
    Kurihara, Miyako
    Nakashima, Chie
    Bosserhoff, Anja Katrin
    Kuniyasu, Hiroki
    ONCOTARGET, 2016, 7 (21) : 31137 - 31152
  • [46] Diagnostic Accuracy of Fine-Needle Aspiration Cytology for Discrimination of Squamous Cell Carcinoma from Adenocarcinoma in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
    Layfield, Lester J.
    Pearson, Lauren
    Walker, Brandon S.
    White, Sandra K.
    Schmidt, Robert L.
    ACTA CYTOLOGICA, 2018, 62 (5-6) : 318 - 326
  • [47] Telomerase catalytic subunit gene expression does not influence survival of patients with squamous cell carcinoma of the larynx and hypopharynx: a case-control study
    Luzar, B
    Poljak, M
    Fischinger, J
    Klopcic, U
    Gale, N
    JOURNAL OF LARYNGOLOGY AND OTOLOGY, 2005, 119 (11): : 917 - 921
  • [48] hMSH2 and hMLH1 gene expression patterns differ between lung adenocarcinoma and squamous cell carcinoma: correlation with patient survival and response to adjuvant chemotherapy treatment
    Vageli, Dimitra P.
    Zaravinos, Apostolos
    Daniil, Zoe
    Dahabreh, Jubrail
    Doukas, Sotirios G.
    Spandidos, Demetrios A.
    Gourgoulianis, Konstantinos I.
    Koukoulis, George K.
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2012, 27 (04): : E400 - E404
  • [49] Prognostic value of NF-κB interacting long non-coding RNA expression in lung adenocarcinoma and lung squamous cell cancer: a study based on the cancer genome atlas datasets
    Fu, Bohua
    Xu, Yuzhu
    Wang, Yi
    Chen, Huilong
    Huang, Zhenli
    Hu, Yinan
    Zhang, Lei
    Wu, Guorao
    Liu, Juan
    Deng, Yanhan
    Mou, Yong
    Wang, Qi
    Qi, Xuefei
    Tao, Yu
    TRANSLATIONAL CANCER RESEARCH, 2018, 7 (01) : 109 - 120
  • [50] Durable clinical response to immunotherapy in EGFR-mutated lung adenocarcinoma with squamous cell carcinoma transformation and high expression of PD-L1 after resistance development: A case report
    Peng, Zhongsheng
    Xu, Yanjun
    CURRENT PROBLEMS IN CANCER: CASE REPORTS, 2022, 8